about
The incidence rate and economic burden of community-acquired pneumonia in a working-age populationEfficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).Etiology and outcome of severe community acquired pneumonia in immunocompetent adults.Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China.The incidence and etiology of community-acquired pneumonia in fever outpatients.Pneumonia part 1: Pathology, presentation and prevention.Pneumonia part 2: signs, symptoms and vaccinations.Current treatment of community-acquired pneumonia.The changing microbiologic epidemiology of community-acquired pneumonia.What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy.Personalized treatment of severe pneumonia in cancer patients.Cardiorespiratory Fitness is Associated with Reduced Risk of Respiratory Diseases in Middle-Aged Caucasian Men: A Long-Term Prospective Cohort Study.Lung abscess in a young patientNon-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study.Gamma-Glutamyltransferase and Future Risk of Pneumonia: A Long-Term Prospective Cohort Study.Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin.Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia.
P2860
Q33652914-3866F9C6-410B-4A22-86A4-8E3AF772D33DQ33929402-D35D28F7-DBAB-4DEA-A922-59CFAEFB7EF9Q34593229-A86938D2-A7A6-4F09-AA8A-276162BF8BC6Q34802736-73B54143-8B41-4556-833D-812C735A3CB3Q37847463-D4334D5E-E3B4-4E2D-8694-73E553790BE2Q37981508-664C9535-9B7E-4C1C-898C-11E8EB07B786Q37991514-D0D1FBE3-D279-4379-A462-F4213D006789Q38105639-24CDB65B-58B3-46BC-B21B-B72271864DA7Q38160635-D28F7F70-1CEE-441E-B25F-BED021195B9FQ38571891-69054820-EFC5-4624-B64C-578921084828Q38613281-AEA2F71D-0CA2-4691-8E53-11E72424D5F7Q38658874-E1A03D39-75AE-49E3-A6BD-9D4C293B42ABQ41892752-7D1589F3-C3B9-4D6A-8F6E-801109496FA4Q47601045-5C14B306-193E-4E6D-90F9-F1B4FD9488F2Q47673786-537C6F51-E73A-408B-B2EC-026FF55D981CQ53706052-97FB7D27-DD1A-4F80-B399-34BB31ECCEACQ53706054-FCF4A327-ECDF-4A1D-B874-D4A3A894C987
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Community-Acquired Pneumonia: An Unfinished Battle
@ast
Community-Acquired Pneumonia: An Unfinished Battle
@en
Community-Acquired Pneumonia: An Unfinished Battle
@en-gb
Community-Acquired Pneumonia: An Unfinished Battle
@nl
type
label
Community-Acquired Pneumonia: An Unfinished Battle
@ast
Community-Acquired Pneumonia: An Unfinished Battle
@en
Community-Acquired Pneumonia: An Unfinished Battle
@en-gb
Community-Acquired Pneumonia: An Unfinished Battle
@nl
altLabel
Community-acquired pneumonia: an unfinished battle
@en
prefLabel
Community-Acquired Pneumonia: An Unfinished Battle
@ast
Community-Acquired Pneumonia: An Unfinished Battle
@en
Community-Acquired Pneumonia: An Unfinished Battle
@en-gb
Community-Acquired Pneumonia: An Unfinished Battle
@nl
P1476
Community-Acquired Pneumonia: An Unfinished Battle
@en
P2093
Girish B. Nair
Michael S. Niederman
P304
P356
10.1016/J.MCNA.2011.08.007
P407
P577
2011-11-01T00:00:00Z